ASCENT digital adherence

The Unitaid-funded ASCENT project (Adherence Support Coalition to End TB) aims to improve treatment outcomes through affordable digital adherence technologies.

[ASCENT digital adherence @digitaladh]

Have you checked our virtual data story?

#ASCENT project is wrapping up after 5 years and there’s so much to be known!

Take a look👀 at our data story available in our website here: https://t.co/AP7fqKIYlh

@KNCVTBPlus @UNITAID @Auruminstitute @PATHtweets @LSHTM
#DAT #TB

[KNCV TB Plus @KNCVTBPlus]

Today is the @UN High Level Meeting (#UNHLM) on antimicrobial resistance (AMR). Did you know that #tuberculosis causes 1/3 #AMR deaths globally?

@KNCVTBPlus supports countries strengthening health systems to #EndTB & other infectious diseases, including AMR. #TogetherWeCanEndTB!

[ASCENT digital adherence @digitaladh]

DON'T MISS OUT because this is a fantastic opportunity to gain valuable insights, ask questions, and connect with peers in the field.

👉To register for this webinar, please visit: https://t.co/hAz3n2A4X5

#DATs #DigitalHealth #tuberculosis #EndTB

[ASCENT digital adherence @digitaladh]

WEBINAR COMING SOON! 💻

We know how challenging it can be to take technical decisions that have implications in the everyday life of so many people. For this reason, we continue to grow our shared-learning platform supported by #DAT implementers and experts in the field.

[ASCENT digital adherence @digitaladh]

🗓 Our next insightful webinar will take place on May 29 under the theme "Global hosting vs. Local hosting, programmatic implementation of DATs".

For this upcoming session we will have a Digital Health expert from @dimagi and local experts from implementing countries!

[ASCENT digital adherence @digitaladh]

Differentiated care through #DigitalAdherenceTechnologies to support people in their #tuberculosis treatment journey!

@KNCVTBPlus
@PATHtweets
@eunice_moturi

#DATs #TB #EndTB #DigitalHealth

[ASCENT digital adherence @digitaladh]

24 HOURS LEFT❗ ⏲

👉 Register now and join us for our webinar session on Differentiated care through #DigitalAdherenceTechnologies (DATs), tailoring support for #PwTB!!

Don't forget to REPOST and SHARE WITH YOUR NETWORKS! 🔄

Register here: https://t.co/zgRofUj4Ze

#TB #EndTB

[ASCENT digital adherence @digitaladh]

24 HOURS LEFT❗ ⏲

👉 Register now and join us for our webinar session on Differentiated care through #DigitalAdherenceTechnologies (DATs), tailoring support for #PwTB!!

Don't forget to REPOST and SHARE WITH YOUR NETWORKS! 🔄

Register here: https://t.co/zgRofUj4Ze

#TB #EndTB

[KNCV TB Plus @KNCVTBPlus]

We're looking for volunteers in the Netherlands! 👀 ⁠
⁠
🤝 @kncvtbplus_nl & @dimagi are aiming at improving #TB awareness among different populations in the #Netherlands with #AI chatbots!
⁠
#TogetherWeCanEndTB⁠
⁠
Register as a volunteer here: https://t.co/abxtIfbuwW

[Nicola Cloete Foster @DrNicolaFoster]

3/4 Findings are now available as a PRE-PRINT 📢

https://t.co/oxu3USRzgd
@LSHTM_TB @CFMcQuaid @amare_wt @KNCVTBPlus @digitaladh @ISEG_LSHTM

[ASCENT digital adherence @digitaladh]

Register for the webinar!
March 27, 2024

Digital Adherence Technologies, Streamlining user engagement!

[KNCV TB Plus @KNCVTBPlus]

The Global DAT Task Force will be hosting the third webinar from their Learning Hub, reflecting on Digital Adherence Technologies supporting the #TB care cascade.

#DAT #TogetherWeCanEndTB #YesWeCanEndTB #WTBD

@digitaladh

Register in the link below

https://t.co/kIj2Ony2WO

[Unitaid @UNITAID]

Innovating TB care in Ethiopia with Unitaid funding!

📲 Smart pillboxes and medication labels are changing the game. The ASCENT project brings digital adherence tech to boost treatment outcomes.

Together, we can make a real impact. 💥

Find out more: https://t.co/yzkiS58jZM

[ASCENT digital adherence @digitaladh]

Check out #ASCENT’s virtual data story on #DAT use to support #TB treatment adherence in Ethiopia, Tanzania, South Africa, Ukraine and The Philippines!

🔗 https://t.co/AP7fqKJwaP

[Unitaid @UNITAID]

A study funded by Unitaid investigates if Digital Adherence Technologies (DATs) can improve tuberculosis treatment outcomes over the standard care. 📊 Can DATs reduce costs, stigma, and health system burden?

Find out more here: https://t.co/9td0nTSmfu

[Wisepill @wisepill]

“ASCENT: A project that involved more than 19,000 people living with tuberculosis across five different countries.” #

[Unitaid @UNITAID]

The team at the Unitaid-funded #ASCENT project highlights the need to fill knowledge gaps on Digital Adherence Technologies (#DAT) for #tuberculosis care.

Read their letter: https://t.co/gHyxSqkKLY

[Global Health EDCTP3 @EDCTP3]

🚨Our 2024 funding opportunities are out!

🔬🦟Over €140 million will be allocated to #research projects working on #HIV, #malaria, NTDs, AMR and much more!

➡️Check out our 2024 Work Programme to learn more: https://t.co/qkoafYUoQg

[KNCV TB Plus @KNCVTBPlus]

Ending the year with #ASCENT Ethiopia's closeout event! 🎉

Highlighting milestones, challenges, and future steps for #DigitalAdherenceTechnologies in TB care.

🌐 Explore more:
https://t.co/yr4y6569bI✨🔍

#EndTB #TBResearch #DigitalHealth @digitaladh

[ASCENT digital adherence @digitaladh]

The use of #DATs can take part in the multifaceted person-centered approach to tackle #TBburden by National TB Programs!

Thanks @TAGTeam_Tweets for this well-crafted guide!

#TB #EndTB #ASCENT

[KNCV TB Plus @KNCVTBPlus]

#RequestForProposals 📢

@UNITAID & @KNCVTBPlus seek partner to improve drug-resistant TB care pathways in low- & middle-income countries.

The deadline to submit a proposal is 26 January 2024. Find out more via the link below!

#EndTB #ASCENT @digitaladh https://t.co/j1rQQMqnGV

[ASCENT digital adherence @digitaladh]

On November 30 of this year, our team based in Ethiopia hosted the #ASCENT research results dissemination meeting and project closeout event.

During this event, it was recognized the positive impacts of #DATs in #TB treatment adherence, especially during #COVID19 times.

[ASCENT digital adherence @digitaladh]

📱#DAT use to support #TB treatment adherence is perceived different by users and providers.

📖Learn more at https://t.co/AP7fqKIYlh
👇👇👇

[ASCENT digital adherence @digitaladh]

From the results of #ASCENT Trial, the willingness to use, the improvement of user-provider relationship, and cost-saving due to reduced clinic visits were seen across study countries‼️

#EndTB #Tuberculosis #DAT

@KNCVTBPlus @UNITAID @Auruminstitute @PATHtweets @LSHTM